|
Market Closed -
Nasdaq
01:30:00 14/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 138.14 USD | +1.67% |
|
+5.56% | +12.55% |
| 11/08 | Global drugmakers invest billions to boost US presence | RE |
| 11/08 | Nucleai And Gilead Sciences Advance AI-Powered Tissue Intelligence Through Large-Scale Oncology ADC Collaboration | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Other Pharmaceuticals | +1.67% | +5.56% | +12.55% | +14.98% | +94.13% | 17TCr |
- Stock Market
- Stocks
- GILD Stock
- Charts Gilead Sciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















